| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,327 | 2,195 | 1,461 | 1,666 | | Selling General and Administrative | 1,493 | 545 | 475 | 958 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,821) | (2,740) | (1,936) | (2,623) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,828) | (3,886) | (509) | 114 | | Earnings Before Interest And Taxes | (7,648) | (6,626) | (2,445) | (2,509) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (7,648) | (6,626) | (2,445) | (2,509) | | Income Tax Expense | (63) | (299) |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,586) | (6,328) | (2,445) | (2,509) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,586) | (6,328) | (2,445) | (2,509) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,586) | ($6,328) | ($2,445) | ($2,509) |
|
0.51% Nasdaq 
0.06 (1.15%) 
Income Statement
